Cowen Suggests Truth to Allergan Rumors


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Traders continue to build up shares of

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Allergan Inc. (NYSE: AGN) as account analyst suggests truth to yesterday's rumor.Cowen analyst Ken Cacciatore cited legal consultants in his note while reporting that the Allergan patent may be issued as early as 4-5 weeks. Cacciatore noted that the patent is being added to the Food and Drug Administration's Orange Book, regardless of the strength of claims. Analysts could confidently model that Allergan would be protected for 30-40 months if no generic applicant is found.Cowen commented that adding restasis to the model would add at least $0.50 and $1.00 to the adjusted EPS estimate in 2014 and 2015, respectively. The average adjusted EPS estimate is reported to be $5.46 in 2014 according to Bloomberg and $5.96 in 2015.Shares of Allergan gained 2.6% yesterday and have traded as high as 5.89% on Friday.
Posted In: Analyst ColorNewsRumorsAnalyst RatingsCowenKen Cacciatore